OTTAWA (Reuters) – Canada on Friday authorized Pfizer-Biontech’s bivalent COVID-19 vaccine booster for children 5 to 11 years of age, according to statement from Health Canada.
Pfizer-BioNTech’s shots are designed to target the BA.4/BA.5 variants of Omicron as well as the original coronavirus variant, and is the first bivalent booster authorized in Canada for 5 to 11 years age group, Health Canada said.
(Reporting by Ismail Shakil in Ottawa)
